Inflammopharmacology
Journal Metrics
(Based on the publications from the last 4 years)
(from 2021-03-01 to roughly 2025-03-01)
(from 2021-03-01 to roughly 2025-03-01)
| Number of papers | 870 |
| H4-Index | 31 |
| TQCC | 9 |
| Average citations | 7.275 |
| Median citations | 3 |
| Impact Factor | 4.600 (based on Web of Science 2023) |
(API-Link)
Categories & Ranks
Metric:
(Based on the publications from the last 4 years)
- # 34 / 150 (Q1) in Immunology
- # 9 / 88 (Q1) in Toxicology
Most cited by this journal
(Based on citations to the other journals in the most recent 30 papers in this journal, at least if metadata about citations were available; last updated 2023-05-10)
Impactful Papers
(Based on publications since 2023; last updated 2025-03-20)
What is really ‘Long COVID’?
Inflammopharmacology
2023-03-28
Ad